Metraipolis › archive › dc_746d49a07080
Gustave Roussy immune score as an independent prognostic factor for treatment response and survival in advanced renal cell carcinoma treated with nivolumab in… — Europe PMC PMID:41179670
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41179670
- DOI
- 10.3389/fonc.2025.1657053
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T06:07:08.099Z
- SHA-256 of the archived text
2e30b4a7cc66b236c81c0cd94125b3add577a2476faa7fa1d223a46b6231de30- Stable URL of this page
https://metraipolis.com/documento/dc_746d49a07080
How to cite
Gustave Roussy immune score as an independent prognostic factor for treatment response and survival in advanced renal cell carcinoma treated with nivolumab in… — Europe PMC PMID:41179670 — Europe PMC (en), https://europepmc.org/article/MED/41179670 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_746d49a07080 (Metraipolis archive dc_746d49a07080, sha256 2e30b4a7cc66b236c81c0cd94125b3add577a2476faa7fa1d223a46b6231de30)
BibTeX
@misc{dc746d49a07080,
title = {Gustave Roussy immune score as an independent prognostic factor for treatment response and survival in advanced renal cell carcinoma treated with nivolumab in… — Europe PMC PMID:41179670},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41179670},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_746d49a07080; sha256 2e30b4a7cc66b236c81c0cd94125b3add577a2476faa7fa1d223a46b6231de30},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41179670. Agents can read the archived copy with the MCP tool read_document.